ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Furyon
|
22K |
7.8M |
15 |
12/09/24 |
12/09/24 |
ASX - By Stock
|
22K
|
7.8M
|
15
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Board Renewal Update
|
|
Furyon
|
108 |
31K |
13 |
04/09/24 |
04/09/24 |
ASX - By Stock
|
108
|
31K
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Board Renewal Update
|
|
Furyon
|
108 |
31K |
42 |
04/09/24 |
04/09/24 |
ASX - By Stock
|
108
|
31K
|
42
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Appendix 4E & Annual Report
|
|
Furyon
|
39 |
11K |
2 |
27/08/24 |
27/08/24 |
ASX - By Stock
|
39
|
11K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Furyon
|
304 |
91K |
14 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
304
|
91K
|
14
|
|
ASX - By Stock
|
RAC |
Re:
Race Oncology - Cashflow Forecast to December 2024
|
|
Furyon
|
27 |
9.3K |
4 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
27
|
9.3K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Race Oncology - Cashflow Forecast to December 2024
|
|
Furyon
|
27 |
9.3K |
5 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
27
|
9.3K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Race Oncology - Cashflow Forecast to December 2024
|
|
Furyon
|
27 |
9.3K |
2 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
27
|
9.3K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Race Oncology - Cashflow Forecast to December 2024
|
|
Furyon
|
27 |
9.3K |
2 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
27
|
9.3K
|
2
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Furyon
|
22K |
7.8M |
4 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
22K
|
7.8M
|
4
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Furyon
|
22K |
7.8M |
4 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
22K
|
7.8M
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Furyon
|
391 |
83K |
15 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
391
|
83K
|
15
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Furyon
|
391 |
83K |
13 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
391
|
83K
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Furyon
|
2.3K |
790K |
13 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
2.3K
|
790K
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Furyon
|
3.0K |
1.0M |
3 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
3.0K
|
1.0M
|
3
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
Furyon
|
2.2K |
776K |
2 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
2.2K
|
776K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
Furyon
|
146 |
45K |
16 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
146
|
45K
|
16
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bonus Options Offer Results
|
|
Furyon
|
35 |
12K |
12 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
35
|
12K
|
12
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Appendix 3Y-Mary Harney
|
|
Furyon
|
17 |
5.7K |
9 |
02/06/24 |
02/06/24 |
ASX - By Stock
|
17
|
5.7K
|
9
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Clarity strengthens Cu-64 network with new supply agreement
|
|
Furyon
|
50 |
17K |
1 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
50
|
17K
|
1
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Clarity strengthens Cu-64 network with new supply agreement
|
|
Furyon
|
50 |
17K |
19 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
50
|
17K
|
19
|
|
ASX - By Stock
|
RAC |
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
|
|
Furyon
|
234 |
67K |
6 |
18/05/24 |
18/05/24 |
ASX - By Stock
|
234
|
67K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
|
|
Furyon
|
234 |
67K |
7 |
18/05/24 |
18/05/24 |
ASX - By Stock
|
234
|
67K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
|
|
Furyon
|
234 |
67K |
7 |
18/05/24 |
18/05/24 |
ASX - By Stock
|
234
|
67K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
|
|
Furyon
|
234 |
67K |
11 |
18/05/24 |
18/05/24 |
ASX - By Stock
|
234
|
67K
|
11
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Furyon
|
905 |
273K |
14 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
905
|
273K
|
14
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Furyon
|
905 |
273K |
24 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
905
|
273K
|
24
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Furyon
|
22K |
7.8M |
6 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
22K
|
7.8M
|
6
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Furyon
|
22K |
7.8M |
5 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
22K
|
7.8M
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
Furyon
|
1.0K |
309K |
11 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
1.0K
|
309K
|
11
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Furyon
|
11K |
4.0M |
13 |
01/03/24 |
01/03/24 |
General
|
11K
|
4.0M
|
13
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Furyon
|
11K |
4.0M |
12 |
01/03/24 |
01/03/24 |
General
|
11K
|
4.0M
|
12
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Receives $4.0m R&D Tax Refund for Financial Year 2023
|
|
Furyon
|
19 |
6.2K |
17 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
19
|
6.2K
|
17
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Receives $4.0m R&D Tax Refund for Financial Year 2023
|
|
Furyon
|
19 |
6.2K |
22 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
19
|
6.2K
|
22
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Receives $4.0m R&D Tax Refund for Financial Year 2023
|
|
Furyon
|
19 |
6.2K |
7 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
19
|
6.2K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Receives $4.0m R&D Tax Refund for Financial Year 2023
|
|
Furyon
|
19 |
6.2K |
4 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
19
|
6.2K
|
4
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Furyon
|
22K |
7.8M |
1 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
22K
|
7.8M
|
1
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Furyon
|
22K |
7.8M |
2 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
22K
|
7.8M
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
Furyon
|
113 |
27K |
15 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
113
|
27K
|
15
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
Furyon
|
2.2K |
776K |
10 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
2.2K
|
776K
|
10
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Furyon
|
22K |
7.8M |
2 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
22K
|
7.8M
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Future of RAC
|
|
Furyon
|
43 |
16K |
10 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
43
|
16K
|
10
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: 2023 AGM Chair's Address to Shareholders
|
|
Furyon
|
19 |
6.1K |
11 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
19
|
6.1K
|
11
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: 2023 AGM Chair's Address to Shareholders
|
|
Furyon
|
19 |
6.1K |
29 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
19
|
6.1K
|
29
|
|
ASX - By Stock
|
RAC Biotech |
Re:
Large BUY - ex insider/ ex CSO / new consultant - Dr Tillett
|
|
Furyon
|
143 |
53K |
4 |
08/09/23 |
08/09/23 |
ASX - By Stock
|
143
|
53K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Board and Management Team Changes
|
|
Furyon
|
450 |
152K |
4 |
25/08/23 |
25/08/23 |
ASX - By Stock
|
450
|
152K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Board and Management Team Changes
|
|
Furyon
|
450 |
152K |
5 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
450
|
152K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Board and Management Team Changes
|
|
Furyon
|
450 |
152K |
9 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
450
|
152K
|
9
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Board and Management Team Changes
|
|
Furyon
|
450 |
152K |
35 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
450
|
152K
|
35
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Board and Management Team Changes
|
|
Furyon
|
450 |
152K |
15 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
450
|
152K
|
15
|
|